GENETIC TECHNOLOGIES LTD's ticker is GENE and the CUSIP is 37185R208. A total of 16 filers reported holding GENETIC TECHNOLOGIES LTD in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $247,000 | -30.2% | 418,797 | +5.3% | 0.00% | – |
| Q1 2019 | $354,000 | +55.9% | 397,797 | -4.1% | 0.00% | – |
| Q4 2018 | $227,000 | -64.4% | 414,697 | -29.2% | 0.00% | -100.0% |
| Q3 2018 | $638,000 | -65.6% | 585,650 | -67.9% | 0.00% | 0.0% |
| Q2 2018 | $1,855,000 | +81.5% | 1,824,906 | +85.7% | 0.00% | 0.0% |
| Q1 2018 | $1,022,000 | -10.5% | 982,980 | -0.2% | 0.00% | 0.0% |
| Q4 2017 | $1,142,000 | +35.8% | 984,580 | -0.5% | 0.00% | 0.0% |
| Q3 2017 | $841,000 | -0.9% | 989,280 | +5.0% | 0.00% | 0.0% |
| Q2 2017 | $849,000 | -15.5% | 942,180 | +12.5% | 0.00% | 0.0% |
| Q1 2017 | $1,005,000 | +37.1% | 837,380 | +23.3% | 0.00% | 0.0% |
| Q4 2016 | $733,000 | -14.5% | 679,080 | +39.5% | 0.00% | -50.0% |
| Q3 2016 | $857,000 | +1.7% | 486,680 | +20.6% | 0.00% | 0.0% |
| Q2 2016 | $843,000 | +16.1% | 403,480 | +28.3% | 0.00% | +100.0% |
| Q1 2016 | $726,000 | -14.7% | 314,380 | -1.0% | 0.00% | -50.0% |
| Q4 2015 | $851,000 | +24.6% | 317,480 | -17.3% | 0.00% | 0.0% |
| Q3 2015 | $683,000 | -63.2% | 383,780 | -37.2% | 0.00% | -50.0% |
| Q2 2015 | $1,857,000 | -45.9% | 610,780 | -6.1% | 0.00% | -42.9% |
| Q1 2015 | $3,430,000 | – | 650,780 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 28,437 | $30,000 | 0.01% |
| Virtu Financial LLC | 37,505 | $39,000 | 0.00% |
| Renaissance Technologies | 982,980 | $1,022,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 2,750 | $3,000 | 0.00% |
| JANE STREET GROUP, LLC | 13,527 | $14,000 | 0.00% |
| UBS Group AG | 3,398 | $3,000 | 0.00% |
| CITIGROUP INC | 300 | $0 | 0.00% |
| MORGAN STANLEY | 1,520 | $2,000 | 0.00% |
| Financial Architects, Inc | 350 | $0 | 0.00% |
| Cambridge Investment Research Advisors, Inc. | 12,000 | $12,000 | 0.00% |